The multikinase inhibitor sorafenib has been used in the treatment of hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma. The Global Sorafenib competition situation market is primarily driven by an increase in the prevalence of chronic diseases like cancer. However, the drug shows adverse side effects when taken along with other drugs or radiotherapy might hamper market growth.
The sorafenib competition situation market is segmented based on type, application, and geography. On the basis of type, sorafenib competition situation market divided into patented drugs and generic drugs. Further, the sorafenib competition situation market is segmented by application into kidney cancer, liver cancer, thyroid cancer, and other. Geographically, the sorafenib competition situation market is sub-divided into North America, Europe, Asia-Pacific, and Rest of the world.
The key market players operating in the sorafenib competition situation market include Bayer, Natco Pharma, Cipla, and Mylan among others.
SORAFENIB COMPETITION SITUATION MARKET SEGMENTS
Market By Type
• Patented Drugs
• Generic Drugs
Market By Application
• Kidney Cancer
• Liver Cancer
• Thyroid Cancer
• Other
Market By Geography
• North America
• Europe
• Asia-Pacific
• Rest of the world
Key Players
• Bayer
• Natco Pharma
• Cipla
• Mylan
Executive Summary
1 Sorafenib Market Overview
1.1 Product Overview and Scope of Sorafenib
1.2 Sorafenib Segment by Type
1.2.1 Global Sorafenib Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Patented Drugs
1.2.3 Generic Drugs
1.3 Sorafenib Segment by Application
1.3.1 Sorafenib Consumption Comparison by Application (2014-2025)
1.3.2 Kidney Cancer
1.3.3 Liver Cancer
1.3.4 Thyroid Cancer
1.3.5 Other
1.4 Global Sorafenib Market by Region
1.4.1 Global Sorafenib Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Sorafenib Market Size
1.5.1 Global Sorafenib Revenue (2014-2025)
1.5.2 Global Sorafenib Production (2014-2025)
2 Global Sorafenib Market Competition by Manufacturers
2.1 Global Sorafenib Production Market Share by Manufacturers (2014-2019)
2.2 Global Sorafenib Revenue Share by Manufacturers (2014-2019)
2.3 Global Sorafenib Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Sorafenib Production Sites, Area Served, Product Types
2.5 Sorafenib Market Competitive Situation and Trends
2.5.1 Sorafenib Market Concentration Rate
2.5.2 Sorafenib Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Sorafenib Production Market Share by Regions
3.1 Global Sorafenib Production Market Share by Regions
3.2 Global Sorafenib Revenue Market Share by Regions (2014-2019)
3.3 Global Sorafenib Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Sorafenib Production
3.4.1 North America Sorafenib Production Growth Rate (2014-2019)
3.4.2 North America Sorafenib Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Sorafenib Production
3.5.1 Europe Sorafenib Production Growth Rate (2014-2019)
3.5.2 Europe Sorafenib Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Sorafenib Production (2014-2019)
3.6.1 China Sorafenib Production Growth Rate (2014-2019)
3.6.2 China Sorafenib Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Sorafenib Production (2014-2019)
3.7.1 Japan Sorafenib Production Growth Rate (2014-2019)
3.7.2 Japan Sorafenib Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Sorafenib Consumption by Regions
4.1 Global Sorafenib Consumption by Regions
4.2 North America Sorafenib Consumption (2014-2019)
4.3 Europe Sorafenib Consumption (2014-2019)
4.4 China Sorafenib Consumption (2014-2019)
4.5 Japan Sorafenib Consumption (2014-2019)
5 Global Sorafenib Production, Revenue, Price Trend by Type
5.1 Global Sorafenib Production Market Share by Type (2014-2019)
5.2 Global Sorafenib Revenue Market Share by Type (2014-2019)
5.3 Global Sorafenib Price by Type (2014-2019)
5.4 Global Sorafenib Production Growth by Type (2014-2019)
6 Global Sorafenib Market Analysis by Applications
6.1 Global Sorafenib Consumption Market Share by Application (2014-2019)
6.2 Global Sorafenib Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Sorafenib Business
7.1 Bayer
7.1.1 Bayer Sorafenib Production Sites and Area Served
7.1.2 Sorafenib Product Introduction, Application and Specification
7.1.3 Bayer Sorafenib Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Natco Pharma
7.2.1 Natco Pharma Sorafenib Production Sites and Area Served
7.2.2 Sorafenib Product Introduction, Application and Specification
7.2.3 Natco Pharma Sorafenib Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Cipla
7.3.1 Cipla Sorafenib Production Sites and Area Served
7.3.2 Sorafenib Product Introduction, Application and Specification
7.3.3 Cipla Sorafenib Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Mylan
7.4.1 Mylan Sorafenib Production Sites and Area Served
7.4.2 Sorafenib Product Introduction, Application and Specification
7.4.3 Mylan Sorafenib Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
8 Sorafenib Manufacturing Cost Analysis
8.1 Sorafenib Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Sorafenib
8.4 Sorafenib Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Sorafenib Distributors List
9.3 Sorafenib Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors
11 Global Sorafenib Market Forecast
11.1 Global Sorafenib Production, Revenue Forecast
11.1.1 Global Sorafenib Production Growth Rate Forecast (2019-2025)
11.1.2 Global Sorafenib Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Sorafenib Price and Trend Forecast (2019-2025)
11.2 Global Sorafenib Production Forecast by Regions (2019-2025)
11.2.1 North America Sorafenib Production, Revenue Forecast (2019-2025)
11.2.2 Europe Sorafenib Production, Revenue Forecast (2019-2025)
11.2.3 China Sorafenib Production, Revenue Forecast (2019-2025)
11.2.4 Japan Sorafenib Production, Revenue Forecast (2019-2025)
11.3 Global Sorafenib Consumption Forecast by Regions (2019-2025)
11.3.1 North America Sorafenib Consumption Forecast (2019-2025)
11.3.2 Europe Sorafenib Consumption Forecast (2019-2025)
11.3.3 China Sorafenib Consumption Forecast (2019-2025)
11.3.4 Japan Sorafenib Consumption Forecast (2019-2025)
11.4 Global Sorafenib Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Sorafenib Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
© 2019 Data N Analysis. All Rights Reserved | Design by Data N Analysis